“venture-capital” Archives

in
Entry Author Date Location
Generate Bio Aims to Reveal Nature’s Protein Secrets, Create New Drugs 09/10/20 Boston
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally 09/03/20 Boston
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Kinnate Raises $98M for Human Tests of Targeted Cancer Therapies 08/26/20 San Francisco
Freenome Tacks on $270M to Advance Blood Tests to Find Cancer Early 08/26/20 San Francisco
Tango Therapeutics Adds $175M, Deal Turns Partner Gilead Into Investor 08/17/20 Boston
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
IgGenix Grabs $10M to Advance Antibody Treatments for Allergies 08/05/20 San Francisco
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists 07/27/20 San Diego
Olema Adds $54M to Start Human Tests of Breast Cancer Drug Candidate 07/22/20 San Francisco
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Dewpoint, Merck Team Up to Tackle HIV Using Condensate Know-How 07/15/20 Boston
Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More 07/10/20 National
VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs 07/09/20 San Diego
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO 07/06/20 San Francisco
Relay Lays $200M IPO Plan to Fund Tests of Protein Motion Cancer Drugs 06/25/20 Boston
In Microbiome Milestone, Finch Therapeutics C. diff Pill Bests Placebo 06/19/20 Boston
Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs 06/18/20 San Diego
Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer 06/17/20 San Diego
Viela Bio Gets FDA Green Light for Rare Autoimmune Disease Treatment 06/12/20 National
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Atlas Venture Raises $400M Fund to Seed Another New Set of Biotechs 06/05/20 Boston
Accent, AstraZeneca Ink Cancer Drug Deal to Block RNA-Modifying Proteins 06/04/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Page 1 of 160 next page »